Madrigal Pharmaceuticals, Inc. (MDGL)

Madrigal Pharmaceuticals Revenue

Madrigal Pharmaceuticals had revenue of $212.80M in the quarter ending June 30, 2025, with 1,353.76% growth. This brings the company's revenue in the last twelve months to $515.55M, up 3,421.98% year-over-year. In the year 2024, Madrigal Pharmaceuticals had annual revenue of $180.13M.

• Revenue (ttm): $515.55M
• Revenue Growth: +3,421.98%
• P/S Ratio: 19.36
• Revenue / Employee: $976,415
• Employees: 528
• Market Cap: 9.92B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	180.13M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.